Penumbra Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Penumbra Inc inventory turnover ratio, the Penumbra Inc's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.1 in the first quarter 2026, yet the ratio remained below the average, as PEN's market remain challenging.Average inventory processing period, for the Penumbra Inc in Mar 31 2026 quarter, has decreased to 332 days, compare to 338 days, in the Dec 31 2025 quarter.

Within Healthcare sector 302 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1035, from total ranking in the fourth quarter 2025 at 1229.

PEN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Penumbra Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PEN Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	5.45 %	6.1 %	9.9 %	14.4 %	4.39 %
Y / Y Cost of Sales Growth	12.09 %	17.62 %	13.44 %	-15.47 %	11.01 %
Inventory Turnover Ratio (TTM)	1.1	1.08	1.05	1.04	1.13
PEN's Total Ranking	# 1035	# 1229	# 766	# 1384	# 1265
Average inventory processing period	333	338	347	349	322
Seq. Inventory Growth	1.62 %	-0.19 %	1.11 %	2.83 %	2.24 %
Seq. Cost of Sales Growth	-1.55 %	7.87 %	-1.02 %	6.64 %	3.3 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 139
Healthcare Sector	# 303
Overall Market	# 1035

Inventory Turnover Ratio Statistics
High	Average	Low
1.46	1.19	1.01
(Dec 31 2018)		(Mar 31 2023)

PEN Company Profile >> Back to PEN Efficiency Comparisons >> Compare PEN Inventory Turnover Ratio to its Competitors

Financial Statements
Penumbra Inc's Inventories	$ 439 Millions	Visit PEN's Balance sheet
Penumbra Inc's Cost of Revenues TTM	$ 474 Millions	Visit PEN's Income Statement
What are PEN's Sales?		Visit PEN's Sales by Segment

Other Inventory Turnover Ratios
Penumbra Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PEN's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PEN's Competitors
Inventory Turnover Ratio for PEN's Suppliers
Inventory Turnover Ratio for PEN's Customers

You may also want to know
PEN's Sales Growth Rates	PEN's Pe Price to earnings ratio	PEN's Receivables Turnover Ratio	PEN's Stock Quote
PEN's Net Income Growth Rates	PEN's Ps Price to Sales ratio	PEN's Sales per Employee	PEN's Asset Turnover Ratio
PEN's Net Margin	PEN's Pb Price to Book ratio	PEN's Financial Strength Ratios	PEN's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Dexcom Inc	2.97	$ 1,854.000 Millions	$ 624 Millions
Msa Safety Inc	2.93	$ 1,020.000 Millions	$ 349 Millions
Nexgel Inc	2.92	$ 6.000 Millions	$ 2 Millions
Abbott Laboratories	2.91	$ 19,741.000 Millions	$ 6,785 Millions
Zai Lab Limited	2.91	$ 128.112 Millions	$ 44 Millions
Mimedx Group Inc	2.87	$ 74.000 Millions	$ 26 Millions
Dentsply Sirona Inc	2.82	$ 1,880.000 Millions	$ 666 Millions
Catalyst Pharmaceuticals Inc	2.82	$ 83.817 Millions	$ 30 Millions
Evofem Biosciences Inc	2.82	$ 4.662 Millions	$ 2 Millions
Livanova Plc	2.80	$ 464.684 Millions	$ 166 Millions
Orthofix Medical Inc	2.79	$ 242.580 Millions	$ 87 Millions
Lifecore Biomedical Inc	2.76	$ 89.000 Millions	$ 32 Millions
Zeo Scientifix Inc	2.76	$ 1.291 Millions	$ 0 Millions
Akebia Therapeutics Inc	2.76	$ 44.127 Millions	$ 16 Millions
Biomerica Inc	2.72	$ 4.142 Millions	$ 2 Millions
Nephros Inc	2.71	$ 8.000 Millions	$ 3 Millions
Neogen Corporation	2.70	$ 478.000 Millions	$ 177 Millions
Merck and Co Inc	2.62	$ 17,158.000 Millions	$ 6,546 Millions
Ligand Pharmaceuticals Incorporated	2.62	$ 32.548 Millions	$ 12 Millions
Electrocore Inc	2.57	$ 4.012 Millions	$ 2 Millions
Anika Therapeutics Inc	2.57	$ 48.000 Millions	$ 19 Millions
Illumina Inc	2.54	$ 1,485.000 Millions	$ 585 Millions
Ani Pharmaceuticals Inc	2.53	$ 361.855 Millions	$ 143 Millions
International Stem Cell Corporation	2.49	$ 3.995 Millions	$ 2 Millions
Quidelortho Corp	2.46	$ 1,462.500 Millions	$ 595 Millions
Avanos Medical Inc	2.44	$ 355.900 Millions	$ 146 Millions
Pro dex Inc	2.44	$ 53.903 Millions	$ 22 Millions
Aquestive Therapeutics Inc	2.43	$ 18.372 Millions	$ 8 Millions
United Therapeutics Corporation	2.41	$ 425.300 Millions	$ 177 Millions
Urogen Pharma Ltd	2.38	$ 14.256 Millions	$ 6 Millions

Date modified: 2026-08-30T14:55:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.